EXPECTATIONS OF PERSONALIZED MEDICINE IN PUBLIC HEALTH: THE POINT OF VIEW OF THE FRENCH AGENCE DE LA BIOMÉDECINE

Abstract

The French Agence de la biomédecine is a public organization established by the law of Bioethics in 2004.
Personalized medicine is therefore analyzed in the
context of the Agency’s missions conferred by the law.
Organ and tissue transplantation, which requires a good
immunological matching of the donor and the recipient,
is by definition “the right treatment for the right person
at the right time”.
Be they autologous or allogeneic, cell transplantations
also require a good immunological matching of the donor
and the recipient and take into account the patients and
their condition in order to personalize the treatment.
Finally, whatever the circumstances, genetic testing
constitutes a personalized medicine. In all cases, it is byplacing the individual in the centre of physicians and
public health professionals’ concerns that ethical and
quality personalized medicine will be developed.